HomeBIOG-B • STO
add
BioGaia AB
Nakaraang pagsara
kr 108.40
Sakop ng araw
kr 107.20 - kr 108.80
Sakop ng taon
kr 93.45 - kr 136.60
Market cap
10.56B SEK
Average na Volume
318.34K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Yahoo Finance
2 oras ang nakalipas
Dow, S&P record highs, Hurricane Milton: Market Domination Overtime
1.03%
0.71%
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 384.12M | 21.86% |
Gastos sa pagpapatakbo | 142.86M | 2.14% |
Net na kita | 111.01M | 37.82% |
Net profit margin | 28.90 | 13.11% |
Kita sa bawat share | — | — |
EBITDA | 147.33M | 58.38% |
Aktuwal na % ng binabayarang buwis | 22.24% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.01B | -26.42% |
Kabuuang asset | 1.90B | -11.88% |
Kabuuang sagutin | 325.40M | 19.08% |
Kabuuang equity | 1.58B | — |
Natitirang share | 100.98M | — |
Presyo para makapag-book | 6.95 | — |
Return on assets | 16.11% | — |
Return on capital | 18.86% | — |
Cash Flow
Net change in cash
| (SEK) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 111.01M | 37.82% |
Cash mula sa mga operasyon | 119.12M | 13.94% |
Cash mula sa pag-invest | -2.24M | 90.87% |
Cash mula sa financing | -699.12M | -136.40% |
Net change in cash | -583.65M | -176.28% |
Malayang cash flow | 100.27M | 67.38% |
Tungkol
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Itinatag
1990
Website
Mga Empleyado
220
